Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy 325 mg/1
asprin, dextromethorphan hydrobromide, phenylephrine bitartrate · TABLET, EFFERVESCENT · Bayer HealthCare LLC.
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy is a tablet, effervescent containing asprin, dextromethorphan hydrobromide, phenylephrine bitartrate at 325 mg/1, taken oral. Manufactured by Bayer HealthCare LLC..
Key Facts
- Brand Name
- Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy
- Generic Name
- asprin, dextromethorphan hydrobromide, phenylephrine bitartrate
- NDC Code (Product)
0280-0024- Manufacturer
- Bayer HealthCare LLC.
- Strength
- 325 mg/1
- Dosage Form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 04/01/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy used for?
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy contains asprin, dextromethorphan hydrobromide, phenylephrine bitartrate. It is a tablet, effervescent taken oral. Consult your doctor for specific uses.
Is Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy a controlled substance?
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy is not classified as a controlled substance by the DEA.
What is the generic name for Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy?
The generic name for Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy is asprin, dextromethorphan hydrobromide, phenylephrine bitartrate. There are no other listed brand versions of asprin, dextromethorphan hydrobromide, phenylephrine bitartrate.
What is the NDC code for Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy 325 mg/1?
The NDC (National Drug Code) for Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy 325 mg/1 is 0280-0024, listed by Bayer HealthCare LLC..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)